These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28781594)

  • 1. Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients.
    Zhang D; Liu X; Wei B; Qiao G; Jiang T; Chen Z
    Int J Endocrinol; 2017; 2017():2645904. PubMed ID: 28781594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATF2-Induced lncRNA GAS8-AS1 Promotes Autophagy of Thyroid Cancer Cells by Targeting the miR-187-3p/ATG5 and miR-1343-3p/ATG7 Axes.
    Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang H
    Mol Ther Nucleic Acids; 2020 Dec; 22():584-600. PubMed ID: 33230459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer.
    Qin Y; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang W; Wu C
    Endocrine; 2018 Mar; 59(3):555-564. PubMed ID: 29327301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance.
    Zhou DL; Liu Q; Xu BH; Li Y; Su X; Ye ZL; Zhang X; Peng JL; Deng L; Tang T; Shao Q; Ma JJ; Yang XH; He CY
    Cancer Biomark; 2020; 29(2):255-264. PubMed ID: 32675393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations.
    Pan W; Zhou L; Ge M; Zhang B; Yang X; Xiong X; Fu G; Zhang J; Nie X; Li H; Tang X; Wei J; Shao M; Zheng J; Yuan Q; Tan W; Wu C; Yang M; Lin D
    Hum Mol Genet; 2016 May; 25(9):1875-84. PubMed ID: 26941397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
    Chen N; Yin D; Lun B; Guo X
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA GAS8-AS1 dinucleotide genetic variant
    Murugan AK; Al-Hindi H; Alzahrani AS
    Endocrine; 2024 Sep; 85(3):1278-1288. PubMed ID: 38580894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of long non-coding RNA BLACAT1 in patients with papillary thyroid carcinoma.
    Liao D; Lv G; Wang T; Min J; Wang Y; Liu S
    Cancer Cell Int; 2018; 18():47. PubMed ID: 29599647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GAS8-AS inhibits colorectal cancer (CRC) cell proliferation by downregulating lncRNA AFAP1-AS1.
    Zhao Y; Chu Y; Sun J; Song R; Li Y; Xu F
    Gene; 2019 Aug; 710():140-144. PubMed ID: 31132513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA GAS8-AS1 is a Novel Prognostic and Diagnostic Biomarker for Pancreatic Cancer.
    Li Z; Yue G; Li M; Yang D; Yue C; Hu W; Lu H
    Crit Rev Eukaryot Gene Expr; 2022; 32(4):83-92. PubMed ID: 35695668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA GAS8-AS1: A novel biomarker in human diseases.
    Li G; Zhang T; Huang K; Zhu Y; Xu K; Gu J; Huang S; Gu C; Zhan R; Shen J
    Biomed Pharmacother; 2021 Jul; 139():111572. PubMed ID: 33838502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion.
    Zha Z; Han Q; Liu W; Huo S
    J Orthop Surg Res; 2020 Feb; 15(1):38. PubMed ID: 32013985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA GAS8-AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation.
    Wu X; Jiang T; Huang R; Xiao X
    Brain Behav; 2021 Jun; 11(6):e02128. PubMed ID: 33942556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAS8 and GAS8-AS1 expression in gastric cancer.
    Esfandi F; Mohammad Rezaei F; Taheri M; Naby Gol M; Kholghi Oskooei V; Namvar A; Ghafouri-Fard S
    Gastroenterol Hepatol Bed Bench; 2019; 12(4):322-327. PubMed ID: 31749921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
    Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O
    Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
    Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
    Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
    He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
    BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.